311 related articles for article (PubMed ID: 31364326)
1. New foot-and-mouth disease vaccine, O JC-R, induce complete protection to pigs against SEA topotype viruses occurred in South Korea, 2014-2015.
Jo HE; Ko MK; Choi JH; Shin SH; Jo H; You SH; Lee MJ; Kim SM; Kim B; Park JH
J Vet Sci; 2019 Jul; 20(4):e42. PubMed ID: 31364326
[TBL] [Abstract][Full Text] [Related]
2. Improved foot-and-mouth disease vaccine, O TWN-R, protects pigs against SEA topotype virus occurred in South Korea.
Choi JH; Ko MK; Shin SH; You SH; Jo HE; Jo H; Lee MJ; Kim SM; Lee JS; Kim B; Park JH
Vet Microbiol; 2019 Sep; 236():108374. PubMed ID: 31500734
[TBL] [Abstract][Full Text] [Related]
3. Improved foot-and-mouth disease vaccine with O PanAsia-2 strain protect pigs against O/Jincheon/SKR/2014 originated from South Korea.
Ko MK; Jo HE; Choi JH; You SH; Shin SH; Jo H; Lee MJ; Kim SM; Kim B; Park JH
Vaccine; 2020 Jan; 38(5):1120-1128. PubMed ID: 31810782
[TBL] [Abstract][Full Text] [Related]
4. Cross-protective efficacy of engineering serotype A foot-and-mouth disease virus vaccine against the two pandemic strains in swine.
Zheng H; Lian K; Yang F; Jin Y; Zhu Z; Guo J; Cao W; Liu H; He J; Zhang K; Li D; Liu X
Vaccine; 2015 Oct; 33(43):5772-5778. PubMed ID: 26431990
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of cross-protection against three topotypes of serotype O foot-and-mouth disease virus in pigs vaccinated with multi-epitope protein vaccine incorporated with poly(I:C).
Cao Y; Lu Z; Li D; Fan P; Sun P; Bao H; Fu Y; Li P; Bai X; Chen Y; Xie B; Liu Z
Vet Microbiol; 2014 Jan; 168(2-4):294-301. PubMed ID: 24345411
[TBL] [Abstract][Full Text] [Related]
6. Control of type O foot-and-mouth disease by vaccination in Korea, 2014-2015.
Park JH; Tark D; Lee KN; Chun JE; Lee HS; Ko YJ; Kye SJ; Kim YJ; Oem JK; Ryoo S; Lim SB; Lee SY; Choi JH; Ko MK; You SH; Lee MH; Kim B
J Vet Sci; 2018 Mar; 19(2):271-279. PubMed ID: 29169228
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of a high quality O
Galdo Novo S; Malirat V; Maradei ED; Pedemonte AR; Espinoza AM; Smitsaart E; Lee KN; Park JH; Bergmann IE
Vaccine; 2018 Mar; 36(12):1570-1576. PubMed ID: 29472132
[TBL] [Abstract][Full Text] [Related]
8. Selection of vaccine strains for serotype O foot-and-mouth disease viruses (2007-2012) circulating in Southeast Asia, East Asia and Far East.
Mahapatra M; Upadhyaya S; Aviso S; Babu A; Hutchings G; Parida S
Vaccine; 2017 Dec; 35(51):7147-7153. PubMed ID: 29157957
[TBL] [Abstract][Full Text] [Related]
9. Molecular Basis of Antigenic Drift in Serotype O Foot-and-Mouth Disease Viruses (2013-2018) from Southeast Asia.
Upadhyaya S; Mahapatra M; Mioulet V; Parida S
Viruses; 2021 Sep; 13(9):. PubMed ID: 34578467
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus-vectored foot-and-mouth disease vaccine confers early and full protection against FMDV O1 Manisa in swine.
Fernandez-Sainz I; Medina GN; Ramirez-Medina E; Koster MJ; Grubman MJ; de Los Santos T
Virology; 2017 Feb; 502():123-132. PubMed ID: 28039799
[TBL] [Abstract][Full Text] [Related]
11. Protection to homologous and heterologous challenge in pigs immunized with vaccine against foot-and-mouth disease type O caused an epidemic in East Asia during 2010/2011.
Park JN; Lee SY; Chu JQ; Lee YJ; Kim RH; Lee KN; Kim SM; Tark DS; Kim B; Park JH
Vaccine; 2014 Apr; 32(16):1882-9. PubMed ID: 24525017
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a genetically modified foot-and-mouth disease virus vaccine candidate generated by reverse genetics.
Li P; Bai X; Sun P; Li D; Lu Z; Cao Y; Fu Y; Bao H; Chen Y; Xie B; Liu Z
BMC Vet Res; 2012 May; 8():57. PubMed ID: 22591597
[TBL] [Abstract][Full Text] [Related]
13. Efficient protection against Asia1 type foot-and-mouth disease using a chimeric vaccine strain suitable for East Asia.
Ko MK; Jo HE; Choi JH; You SH; Shin SH; Hwang SY; Jo H; Kim HM; Lee MJ; Kim SM; Kim B; Park JH
Vet Microbiol; 2021 Feb; 253():108975. PubMed ID: 33418393
[TBL] [Abstract][Full Text] [Related]
14. A foot-and-mouth disease SAT2 vaccine protects swine against experimental challenge with a homologous virus strain, irrespective of mild pathogenicity in this species.
Mouton L; Dekker A; Bleijenberg M; Blanchet M; Coco-Martin J; Hudelet P; Goutebroze S
Vaccine; 2018 Apr; 36(15):2020-2024. PubMed ID: 29510916
[TBL] [Abstract][Full Text] [Related]
15. Determination of optimal age for single vaccination of growing pigs with foot-and-mouth disease bivalent vaccine in South Korea.
Kim AY; Tark D; Kim H; Kim JS; Lee JM; Kwon M; Bae S; Kim B; Ko YJ
J Vet Med Sci; 2017 Nov; 79(11):1822-1825. PubMed ID: 28943596
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of novel inactivated vaccines for the SAT 1, SAT 2 and SAT 3 serotypes of foot-and-mouth disease in pigs.
Jo HE; You SH; Choi JH; Ko MK; Shin SH; Song J; Jo H; Lee MJ; Kim SM; Kim B; Park JH
Virol J; 2019 Dec; 16(1):156. PubMed ID: 31842907
[TBL] [Abstract][Full Text] [Related]
17. Chimeric vaccine strain of type O foot-and-mouth disease elicits a strong immune response in pigs against ME-SA and SEA topotypes.
Ko MK; Jo HE; Choi JH; You SH; Shin SH; Jo H; Lee MJ; Kim SM; Kim B; Park JH
Vet Microbiol; 2019 Feb; 229():124-129. PubMed ID: 30642587
[TBL] [Abstract][Full Text] [Related]
18. Vaccine strain of O/ME-SA/Ind-2001e of foot-and-mouth disease virus provides high immunogenicity and broad antigenic coverage.
Lee G; Hwang JH; Park JH; Lee MJ; Kim B; Kim SM
Antiviral Res; 2020 Oct; 182():104920. PubMed ID: 32828822
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with a FMDV O Mya98 lineage virus in pigs 4 and 7 days post vaccination.
Wilna V; Hong NT; Geoffrey FT; Jacqueline MM; Jianning W; Van Phuc K; Ngon QV; Phuong le TT; Hung D; Hanh TX; Van Hung V; Anh le TQ; Tien MT; Quang le TV; Long NT; Nagendrakumar SB
Vaccine; 2015 Jun; 33(24):2778-85. PubMed ID: 25917677
[TBL] [Abstract][Full Text] [Related]
20. Effects of germanium biotite supplement on immune responses of vaccinated mini-pigs to foot-and-mouth disease virus challenge.
Jung M; Park HT; Park JH; Lee KN; Shin SW; Shin MK; Sung KY; Jung YK; Kim B; Yoo HS
Immunol Invest; 2015; 44(1):101-12. PubMed ID: 25058651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
